91
Participants
Start Date
June 15, 2022
Primary Completion Date
January 3, 2023
Study Completion Date
June 21, 2023
CCH-aaes
Administered by subcutaneous injection.
Antifibrinolytic Agent
Self-administered by participants enrolled in Cohort 7.
Endo Clinical Trial Site #11, New York
Endo Clinical Trial Site #13, Miami
Endo Clinical Trial Site #8, Coral Gables
Endo Clinical Trial Site #1, Nashville
Endo Clinical Trial Site #3, Chicago
Endo Clinical Trial Site #5, Pflugerville
Endo Clinical Trial Site #12, Greenwood Village
Endo Clinical Trial Site #6, Scottsdale
Endo Clinical Trial Site #4, Beverly Hills
Endo Clinical Trial Site #9, Encinitas
Endo Clinical Trial Site #7, Solana Beach
Endo Clinical Trial Site #10, San Diego
Endo Clinical Trial Site #2, Metairie
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY